Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.

Mr. Frederick T. Sullivan

Име	Пазарна капитализация
SofWave Medical Ltd.	0M
Eiken Chemical Co., Ltd.	0M
QHSLab, Inc.	0M
Vitrolife AB (publ)	0M
ReWalk Robotics Ltd.	0M
Bone Biologics Corporation	0M
Hyperfine, Inc.	0M
Sinocare Inc.	0M
Viemed Healthcare, Inc.	0M
Bio-Rad Laboratories, Inc.	0M
Implantica AG	0M

Senseonics Holdings, Inc.

Senseonics Holdings, Inc. Списък на конкурентите

Основни конкуренти